Kontos, C., Bounkari, O. E., Krammer, C., Sinitski, D., Hille, K., Zan, C., . . . Bernhagen, J. (2020). Designed CXCR4 mimic acts as a soluble chemokine receptor that blocks atherogenic inflammation by agonist-specific targeting. Nature Portfolio.
Chicago Style (17th ed.) CitationKontos, Christos, et al. Designed CXCR4 Mimic Acts as a Soluble Chemokine Receptor That Blocks Atherogenic Inflammation by Agonist-specific Targeting. Nature Portfolio, 2020.
MLA (8th ed.) CitationKontos, Christos, et al. Designed CXCR4 Mimic Acts as a Soluble Chemokine Receptor That Blocks Atherogenic Inflammation by Agonist-specific Targeting. Nature Portfolio, 2020.
Warning: These citations may not always be 100% accurate.